Previous Close | 6.56 |
Open | 6.67 |
Bid | 6.69 x 1400 |
Ask | 10.78 x 1100 |
Day's Range | 6.59 - 6.89 |
52 Week Range | 3.49 - 10.39 |
Volume | |
Avg. Volume | 348,683 |
Market Cap | 274.227M |
Beta (5Y Monthly) | 2.47 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.85 |
Earnings Date | Oct 31, 2022 - Nov 04, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for APEN
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -23.81% and 7.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.